Abstract

Recent years witnessed the discovery of ubiquitous and diverse 5′-end RNA cap-like modifications in prokaryotes as well as in eukaryotes. These non-canonical caps include metabolic cofactors, such as NAD+/NADH, FAD, cell wall precursors UDP-GlcNAc, alarmones, e.g. dinucleotides polyphosphates, ADP-ribose and potentially other nucleoside derivatives. They are installed at the 5′ position of RNA via template-dependent incorporation of nucleotide analogues as an initiation substrate by RNA polymerases. However, the discovery of NAD-capped processed RNAs in human cells suggests the existence of alternative post-transcriptional NC capping pathways. In this review, we compiled growing evidence for a number of these other mechanisms which produce various non-canonically capped RNAs and a growing repertoire of capping small molecules. Enzymes shown to be involved are ADP-ribose polymerases, glycohydrolases and tRNA synthetases, and may potentially include RNA 3′-phosphate cyclases, tRNA guanylyl transferases, RNA ligases and ribozymes. An emerging rich variety of capping molecules and enzymes suggests an unrecognized level of complexity of RNA metabolism.

Highlights

  • Cell fitness is highly dependent on fast and adequate changes of gene expression to cope with changing conditions

  • This review focuses on known and potential alternative pathways of NC RNA capping with 6 abundant AMP analogues

  • We speculate that enzymes from the flavin mononucleotide adenylyl transferase (FMNAT) family could be a possible candidate, analogically to nicotinamide mononucleotide adenylyltransferases (NMNATs) as candidates for Nicotinamide dinucleotide (NAD)+ capping

Read more

Summary

Introduction

Cell fitness is highly dependent on fast and adequate changes of gene expression to cope with changing conditions. Canonical eukaryotic 50 RNA caps are attached to the nascent RNA early during its synthesis by RNA polymerase (RNAP) and can subsequently affect almost all its cellular roles. The phosphorylation state of RNA 50 end defines RNA longevity and susceptibility to degradation, affecting gene regulation and cell survival. Besides the high percentage of diphosphorylated RNA ( ppRNA; 35%–50% mRNA) [6], a surprising number of different cap-like structures, including dinucleotide analogues, metabolic cofactors and cell wall precursors, were revealed at the 50 ends of bacterial and eukaryotic RNAs [7,8,9,10]. The discovery of bacterial non-canonical (NC) caps challenged the perception of eukaryotic RNA 50 end uniqueness [8,9,11,12,13,14] blasting off the new research field of RNA 50 end epitranscriptomics

Canonical 50 RNA caps and capping mechanism
RNA ligases
RNA 30-phosphate cyclase RtcA
FAD capping by RNA polymerase and potentially flavin biosynthesis 16 enzymes
10. Non-canonical RNA capping by ribozymes
11. Protein caps of the viral genome
12. The extent of NC capping and cellular roles of capped RNAs are still unclear
Findings
13. Summary and perspectives
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call